The Ensign Group Inc (ENSG)vsFresenius Medical Care Corporation (FMS)
ENSG
The Ensign Group Inc
$176.13
-0.62%
HEALTHCARE · Cap: $10.38B
FMS
Fresenius Medical Care Corporation
$24.01
-4.95%
HEALTHCARE · Cap: $13.29B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 253% more annual revenue ($19.36B vs $5.49B). ENSG leads profitability with a 6.9% profit margin vs 4.9%. FMS appears more attractively valued with a PEG of 0.88. ENSG earns a higher WallStSmart Score of 60/100 (C+).
ENSG
Buy60
out of 100
Grade: C+
FMS
Buy50
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-39.8%
Fair Value
$151.60
Current Price
$176.13
$24.53 premium
Margin of Safety
+68.5%
Fair Value
$76.46
Current Price
$24.01
$52.45 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
17.3% revenue growth
Reasonable price relative to book value
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
Expensive relative to growth rate
Moderate valuation
6.9% margin — thin
Grey zone — moderate risk
ROE of 7.1% — below average capital efficiency
4.9% margin — thin
Revenue declined 5.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : ENSG
The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 17.3% demonstrates continued momentum.
Bull Case : FMS
The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.
Bear Case : ENSG
The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.
Bear Case : FMS
The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.
Key Dynamics to Monitor
ENSG profiles as a growth stock while FMS is a value play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.82 — expect wider price swings.
ENSG is growing revenue faster at 17.3% — sustainability is the question.
ENSG generates stronger free cash flow (119M), providing more financial flexibility.
Bottom Line
ENSG scores higher overall (60/100 vs 50/100) and 17.3% revenue growth. FMS offers better value entry with a 68.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
The Ensign Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?